SEARCH

SEARCH BY CITATION

References

  • Aguilar, J.A., Zavala, A.N., Diaz-Perez, C., Cervantes, C., Diaz-Perez, A.L., and Campos-Garcia, J. (2006) The atu and liu clusters are involved in the catabolic pathways for acyclic monoterpenes and leucine in Pseudomonas aeruginosa. Appl Environ Microbiol 72: 20702079.
  • Aires, J.R., Kohler, T., Nikaido, H., and Plesiat, P. (1999) Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob Agents Chemother 43: 26242628.
  • Aspedon, A., Palmer, K., and Whiteley, M. (2006) Microarray analysis of the osmotic stress response in Pseudomonas aeruginosa. J Bacteriol 188: 27212725.
  • Bagge, N., Ciofu, O., Hentzer, M., Campbell, J.I., Givskov, M., and Hoiby, N. (2002) Constitutive high expression of chromosomal beta-lactamase in Pseudomonas aeruginosa caused by a new insertion sequence (IS1669) located in ampD. Antimicrob Agents Chemother 46: 34063411.
  • Bantinaki, E., Kassen, R., Knight, C.G., Robinson, Z., Spiers, A.J., and Rainey, P.B. (2007) Adaptive divergence in experimental populations of Pseudomonas fluorescens. III. Mutational origins of wrinkly spreader diversity. Genet 176: 441453.
  • Barth, A.L., and Pitt, T.L. (1996) The high amino-acid content of sputum from cystic fibrosis patients promotes growth of auxotrophic Pseudomonas aeruginosa. J Med Microbiol 45: 110119.
  • Boucher, J.C., Yu, H., Mudd, M.H., and Deretic, V. (1997) Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection. Infect Immun 65: 38383846.
  • Bragonzi, A., Paroni, M., Nonis, A., Cramer, N., Montanari, S., Rejman, J., et al. (2009) Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence. Am J Respir Crit Care Med 180: 138145.
  • Burns, J.L., Gibson, R.L., McNamara, S., Yim, D., Emerson, J., Rosenfeld, M., et al. (2001) Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis 183: 444452.
  • Cabral, D.A., Loh, B.A., and Speert, D.P. (1987) Mucoid Pseudomonas aeruginosa resists nonopsonic phagocytosis by human neutrophils and macrophages. Pediatr Res 22: 429431.
  • Carterson, A.J., Morici, L.A., Jackson, D.W., Frisk, A., Lizewski, S.E., Jupiter, R., et al. (2004) The transcriptional regulator AlgR controls cyanide production in Pseudomonas aeruginosa. J Bacteriol 186: 68376844.
  • Choi, K.H., and Schweizer, H.P. (2005) An improved method for rapid generation of unmarked Pseudomonas aeruginosa deletion mutants. BMC Microbiol 5: 30.
  • Ciofu, O., Fussing, V., Bagge, N., Koch, C., and Hoiby, N. (2001) Characterization of paired mucoid/non-mucoid Pseudomonas aeruginosa isolates from Danish cystic fibrosis patients: antibiotic resistance, beta-lactamase activity and RiboPrinting. J Antimicrob Chemother 48: 391396.
  • Ciofu, O., Lee, B., Johannesson, M., Hermansen, N.O., Meyer, P., and Hoiby, N. (2008) Investigation of the algT operon sequence in mucoid and non-mucoid Pseudomonas aeruginosa isolates from 115 Scandinavian patients with cystic fibrosis and in 88 in vitro non-mucoid revertants. Microbiology 154: 103113.
  • Elena, S.F., and Lenski, R.E. (2003) Evolution experiments with microorganisms: the dynamics and genetic bases of adaptation. Nat Rev Genet 4: 457469.
  • Firoved, A.M., and Deretic, V. (2003) Microarray analysis of global gene expression in mucoid Pseudomonas aeruginosa. J Bacteriol 185: 10711081.
  • Goldberg, J.B., and Pier, G.B. (1996) Pseudomonas aeruginosa lipopolysaccharides and pathogenesis. Trends Microbiol 4: 490494.
  • Govan, J.R., and Deretic, V. (1996) Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60: 539574.
  • Gutierrez, C., and Devedjian, J.C. (1991) Osmotic induction of gene osmC expression in Escherichia coli K12. J Mol Biol 220: 959973.
  • Gutierrez, C., Gordia, S., and Bonnassie, S. (1995) Characterization of the osmotically inducible gene osmE of Escherichia coli K-12. Mol Microbiol 16: 553563.
  • Hancock, R.E. (1997) The bacterial outer membrane as a drug barrier. Trends Microbiol 5: 3742.
  • Hancock, R.E., and Speert, D.P. (2000) Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment. Drug Resist Updat 3: 247255.
  • Hansen, C.R., Pressler, T., and Hoiby, N. (2008) Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience. J Cyst Fibros 7: 523530.
  • Hansen, S.K., Haagensen, J.A., Gjermansen, M., Jorgensen, T.M., Tolker-Nielsen, T., and Molin, S. (2007) Characterization of a Pseudomonas putida rough variant evolved in a mixed-species biofilm with Acinetobacter sp. strain C6. J Bacteriol 189: 49324943.
  • Hoang, T.T., Karkhoff-Schweizer, R.R., Kutchma, A.J., and Schweizer, H.P. (1998) A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. Gene 212: 7786.
  • Høiby, N., and Frederiksen, B. (2000) Microbiology of cystic fibrosis. In Cystic Fibrosis, 2nd edn. Hodson, M.E., and Geddes, D.M. (eds). London, UK: Hodder Arnold, pp. 83107.
  • Høiby, N., Krogh Johansen, H., Moser, C., Song, Z., Ciofu, O., and Kharazmi, A. (2001) Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. Microbes Infect 3: 2335.
  • Høiby, N., Frederiksen, B., and Pressler, T. (2005) Eradication of early Pseudomonas aeruginosa infection. J Cyst Fibros 4 (Suppl. 2): 4954.
  • Holloway, B.W., and Morgan, A.F. (1986) Genome organization in Pseudomonas. Annu Rev Microbiol 40: 79105.
  • Islam, S., Oh, H., Jalal, S., Karpati, F., Ciofu, O., Hoiby, N., and Wretlind, B. (2009) Chromosomal mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Clin Microbiol Infect 15: 6066.
  • Jalal, S., Ciofu, O., Hoiby, N., Gotoh, N., and Wretlind, B. (2000) Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob Agents Chemother 44: 710712.
  • Jeannot, K., Elsen, S., Kohler, T., Attree, I., Van Delden, C., and Plesiat, P. (2008) Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump. Antimicrob Agents Chemother 52: 24552462.
  • Jelsbak, L., Johansen, H.K., Frost, A.L., Thogersen, R., Thomsen, L.E., Ciofu, O., et al. (2007) Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients. Infect Immun 75: 22142224.
  • Johansen, H.K., and Hoiby, N. (1992) Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. Thorax 47: 109111.
  • Kessler, B., De Lorenzo, V., and Timmis, K.N. (1992) A general system to integrate lacZ fusions into the chromosomes of gram-negative eubacteria: regulation of the Pm promoter of the TOL plasmid studied with all controlling elements in monocopy. Mol Gen Genet 233: 293301.
  • Koch, A.K., Kappeli, O., Fiechter, A., and Reiser, J. (1991) Hydrocarbon assimilation and biosurfactant production in Pseudomonas aeruginosa mutants. J Bacteriol 173: 42124219.
  • Koch, C. (2002) Early infection and progression of cystic fibrosis lung disease. Pediatr Pulmonol 34: 232236.
  • Koch, C., and Hoiby, N. (1993) Pathogenesis of cystic fibrosis. Lancet 341: 10651069.
  • Kolter, R. (1999) Growth in studying the cessation of growth. J Bacteriol 181: 697699.
  • Lee, B., Haagensen, J.A., Ciofu, O., Andersen, J.B., Hoiby, N., and Molin, S. (2005) Heterogeneity of biofilms formed by nonmucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis. J Clin Microbiol 43: 52475255.
  • Linares, J.F., Lopez, J.A., Camafeita, E., Albar, J.P., Rojo, F., and Martinez, J.L. (2005) Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeruginosa. J Bacteriol 187: 13841391.
  • Lizewski, S.E., Schurr, J.R., Jackson, D.W., Frisk, A., Carterson, A.J., and Schurr, M.J. (2004) Identification of AlgR-regulated genes in Pseudomonas aeruginosa by use of microarray analysis. J Bacteriol 186: 56725684.
  • De Lorenzo, V., and Timmis, K.N. (1994) Analysis and construction of stable phenotypes in gram-negative bacteria with Tn5- and Tn10-derived minitransposons. Methods Enzymol 235: 386405.
  • Mahenthiralingam, E., Campbell, M.E., and Speert, D.P. (1994) Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect Immun 62: 596605.
  • Martin, D.W., Schurr, M.J., Mudd, M.H., Govan, J.R., Holloway, B.W., and Deretic, V. (1993) Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. Proc Natl Acad Sci USA 90: 83778381.
  • Martin, R.R., Marshall, V.D., Sokatch, J.R., and Unger, L. (1973) Common enzymes of branched-chain amino acid catabolism in Pseudomonas putida. J Bacteriol 115: 198204.
  • Mathee, K., Ciofu, O., Sternberg, C., Lindum, P.W., Campbell, J.I., Jensen, P., et al. (1999) Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung. Microbiology 145: 13491357.
  • Morici, L.A., Carterson, A.J., Wagner, V.E., Frisk, A., Schurr, J.R., Honer zu Bentrup, K., et al. (2007) Pseudomonas aeruginosa AlgR represses the Rhl quorum-sensing system in a biofilm-specific manner. J Bacteriol 189: 77527764.
  • Palmer, K.L., Aye, L.M., and Whiteley, M. (2007) Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. J Bacteriol 189: 80798087.
  • Pamp, S.J., and Tolker-Nielsen, T. (2007) Multiple roles of biosurfactants in structural biofilm development by Pseudomonas aeruginosa. J Bacteriol 189: 25312539.
  • Pedersen, S.S. (1992) Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis. APMIS Suppl 28: 179.
  • Rahme, L.G., Stevens, E.J., Wolfort, S.F., Shao, J., Tompkins, R.G., and Ausubel, F.M. (1995) Common virulence factors for bacterial pathogenicity in plants and animals. Science 268: 18991902.
  • Rhodius, V.A., Suh, W.C., Nonaka, G., West, J., and Gross, C.A. (2006) Conserved and variable functions of the sigmaE stress response in related genomes. Plos Biol 4: e2.
  • Rohwer, F., and Edwards, R. (2002) The Phage Proteomic Tree: a genome-based taxonomy for phage. J Bacteriol 184: 45294535.
  • Rowen, D.W., and Deretic, V. (2000) Membrane-to-cytosol redistribution of ECF sigma factor AlgU and conversion to mucoidy in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Mol Microbiol 36: 314327.
  • Sanchez, P., Linares, J.F., Ruiz-Diez, B., Campanario, E., Navas, A., Baquero, F., and Martinez, J.L. (2002) Fitness of in vitro selected Pseudomonas aeruginosa nalB and nfxB multidrug resistant mutants. J Antimicrob Chemother 50: 657664.
  • Schnabel, H., and Schnabel, R. (1990) An organ-specific differentiation gene, pha-1, from Caenorhabditis elegans. Science 250: 686688.
  • Smith, E.E., Buckley, D.G., Wu, Z., Saenphimmachak, C., Hoffman, L.R., D'Argenio, D.A., et al. (2006) Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci USA 103: 84878492.
  • Spencer, R.C. (1996) An 8 year Microbe Base survey of the epidemiology, frequency and antibiotic susceptibility of Pseudomonas aeruginosa hospital isolates in the United Kingdom. J Antimicrob Chemother 37: 295301.
  • Stover, C.K., Pham, X.Q., Erwin, A.L., Mizoguchi, S.D., Warrener, P., Hickey, M.J., et al. (2000) Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature 406: 959964.
  • Tan, M.W., Rahme, L.G., Sternberg, J.A., Tompkins, R.G., and Ausubel, F.M. (1999) Pseudomonas aeruginosa killing of Caenorhabditis elegans used to identify P. aeruginosa virulence factors. Proc Natl Acad Sci USA 96: 24082413.
  • Tart, A.H., Blanks, M.J., and Wozniak, D.J. (2006) The AlgT-dependent transcriptional regulator AmrZ (AlgZ) inhibits flagellum biosynthesis in mucoid, nonmotile Pseudomonas aeruginosa cystic fibrosis isolates. J Bacteriol 188: 64836489.
  • Terry, J.M., Pina, S.E., and Mattingly, S.J. (1991) Environmental conditions which influence mucoid conversion Pseudomonas aeruginosa PAO1. Infect Immun 59: 471477.
  • Thomsen, L.E., Slutz, S.S., Tan, M.W., and Ingmer, H. (2006) Caenorhabditis elegans is a model host for Listeria monocytogenes. Appl Environ Microbiol 72: 17001701.
  • Wiehlmann, L., Wagner, G., Cramer, N., Siebert, B., Gudowius, P., Morales, G., et al. (2007) Population structure of Pseudomonas aeruginosa. Proc Natl Acad Sci USA 104: 81018106.
  • Wolfgang, M.C., Kulasekara, B.R., Liang, X., Boyd, D., Wu, K., Yang, Q., et al. (2003) Conservation of genome content and virulence determinants among clinical and environmental isolates of Pseudomonas aeruginosa. Proc Natl Acad Sci USA 100: 84848489.
  • Wood, L.F., and Ohman, D.E. (2009) Use of cell wall stress to characterize sigma 22 (AlgT/U) activation by regulated proteolysis and its regulon in Pseudomonas aeruginosa. Mol Microbiol 72: 183201.
  • Wu, W., Badrane, H., Arora, S., Baker, H.V., and Jin, S. (2004) MucA-mediated coordination of type III secretion and alginate synthesis in Pseudomonas aeruginosa. J Bacteriol 186: 75757585.
  • Wylie, J.L., and Worobec, E.A. (1995) The OprB porin plays a central role in carbohydrate uptake in Pseudomonas aeruginosa. J Bacteriol 177: 30213026.
  • Yang, L., Haagensen, J.A., Jelsbak, L., Johansen, H.K., Sternberg, C., Hoiby, N., and Molin, S. (2008) In situ growth rates and biofilm development of Pseudomonas aeruginosa populations in chronic lung infections. J Bacteriol 190: 27672776.
  • Zinser, E.R., and Kolter, R. (1999) Mutations enhancing amino acid catabolism confer a growth advantage in stationary phase. J Bacteriol 181: 58005807.